340B Overview: Best Purchasing Practices for Compliance & Benefit

Educational

Shawn Wood, MBA, CPHT, 340B ACE, is Director of System 340B Oversight and Compliance for Beth Israel Lahey Health (BILH), overseeing hospitals’ onsite 340B Program or split-billing, 340B advocacy and overall 340B Program compliance. BILH’s 340B program is a large program with significant regulatory, compliance, financial, IS, and workflow complexities that supports its financial health, which he supports.

Shawn has 14 years of experience in the 340B Program and more than 20 years in hospital pharmacy settings. His career began as a pharmacy technician, then pharmacy supply chain and then moved to administering the 340B Program. His 340B expertise spans hospital based and contract pharmacy programs, pharmacy supply chain and includes, a Pharmacy Technician Certification, an advanced certification for 340B or ACE, a Bachelors in Healthcare Management from Cambridge College and an MBA from UMass-Boston. He has also spoken nationally at the 340B Conference on best practice and, twice locally at Massachusetts Society of Health-System Pharmacists (MSHP) on the expanding role of Pharmacy Technicians and the 340B Program. Most recently he received from MSHP the
Technician of the Year Award for his work on Beth Israel Deaconess Medical Center’s 340B Program.

Shawn Wood Overview of "The 340B Program; Overview to Best Practices" Presentation at HCP Rx Buyer's Conference in Summer 2023

LEARNING OBJECTIVES:

• Recognize the basics of the 340B Program and identify compliance requirements
• Explain potential workflow issues related to the 340B Program and mitigation strategies
• Summarize purchasing strategies to optimize the 340B Program
• Identify the resources available to support the 340B Program

Latest Videos

View all Videos

Executive Insights

Executive Interview with Terry Terifay

Mar 26, 2025

Terry Terify, the Chief Commercial Officer of Azurity Pharmaceuticals, shares insights about the company's mission to serve overlooked patient populations. With nearly three decades of experience in the pharmaceutical industry, Terry highlights Azurity's focus on developing dosage formulations for pediatric, adult, and geriatric patients with unmet needs. The company boasts a diverse portfolio of 22 promoted products across six therapeutic categories, including oncology and cardiovascular.

Executive Insights

Executive Interview with Hinnah Farooqi

Feb 25, 2025

Hinnah Farooqi serves as the Director of Pharmacy at New York Presbyterian in Queens, a diverse hospital with 500 beds. She discusses the hospital's efforts to improve efficiency and patient safety by using more automation, like RFID technology called Intelligard. Hinnah also emphasizes teamwork with the central sterile team and the hospital's focus on developing leaders and improving management skills through partnerships and internal programs.

Executive Interview with Valerie Hoffman

Feb 25, 2025

Valerie Hoffman is the Associate Marketing Director at Long Grove Pharmaceuticals. Valerie prioritizes drug safety and aims to enhance it through clear, distinctive labeling. She also emphasizes open communication in leadership and works to build strong customer relationships.